Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold
AstraZeneca said it had paused trials of its experimental coronavirus vaccine because of an unexplained illness in a study participant.
Full Article
Serum Institute puts India trials of AstraZeneca's Covid-19 vaccine on hold
Khaleej Times
0 shares
1 views
You might like
Related news coverage
Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report| Oneindia
Oneindia
After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination..
-
Serum Institute to manufacture 200mn doses of Covid-19 vaccine
Mid-Day
-
Serum Institute CEO lauds PM Narendra Modi's COVID-19 vaccine vision day after challenging Centre on pandemic response
DNA
-
Narendra Modi's 'pharmadiplomacy': India's COVID vaccines to 'help all humanity'
Mid-Day
-
Adar Poonawalla: Will Govt have 80,000 crores available over the next one year?
Mid-Day
Advertisement
More coverage
AstraZeneca Coronavirus Vaccine Trials Remain Stalled In The U.S.
Newsy
Watch VideoA coronavirus vaccine trial in the U.S. is still on hold.
AstraZeneca released its trial blueprint Saturday..
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla asks
DNA
-
Can Centre procure Rs 80,000 crore to buy, distribute COVID-19 vaccine across India? SII CEO Adar Poonawalla
DNA
-
Mumbai: KEM hospital gets gets nod for COVID-19 vaccine trials
Mid-Day
-
Phase 3 trial of Oxford vaccine begins in Pune
IndiaTimes